Search Orphan Drug Designations and Approvals
-
Generic Name: | bendamustine hydrochloride with betadex sulfobutyl ether sodium |
---|---|
Date Designated: | 09/10/2013 |
Orphan Designation: | Treatment of chronic lymphocytic leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
BendaRx Corp. 1000 De La Gauchetiere W Ste 2400 Montréal Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-